News & Events
-
March 14, 2023
C-Path Welcomes BioCentury Inc. Co-Founder Bernstein to Board of Directors
TUCSON, Ariz., March 14, 2023 — Critical Path Institute (C-Path) today announced the appointment of Karen Bernstein, Ph.D., to its Board of Directors. Bernstein will help steer the strategic vision and mission of the nonprofit organization as it continues to accelerate the path to a healthier world.
-
March 8, 2023
C-Path Welcomes TransPerfect Life Sciences
C-Path is proud to welcome TransPerfect Life Sciences as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Comprised of 21 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, eCOA Consortium members collaborate in a pre-competitive environment to support... -
March 2, 2023
C-Path Impact
Critical Path Institute (C-Path) has achieved demonstrable results across several scientific and medical industries with significant increases in market valuation. Below are a few metrics that speak to the impact C-Path has made: Alzheimer’s disease: The AD drug market valuation in 2016 was estimated at about $3B, when drugs to prevent the onset of dementia... -
February 22, 2023
Breaking Down Barriers in Support of Patients with Rare Diseases
You’re invited to join C-Path’s Gina Calarco Smith at the upcoming Breaking Down Barriers in Support of Rare Diseases webinar. Smith, Scientific Director of Pediatrics at C-Path, will be on a panel of rare disease experts who will break down the latest in drug development, clinical trials, patient advocacy and more. Hosted by Labcorp on Wednesday, February... -
February 20, 2023
3rd PSTC Japan Safety Biomarker Workshop (presentations available)
2023 Presentations PMDA’s Perspective on the Evaluation of Novel Biomarkers (Hisanao Izumi, PhD) Biomolecular Needling System for Medicals (Beomjoon Kim, PhD) Novel Biomarker Exploration Using SOMAscan (Noriaki Arakawa) Japanese Healthy Volunteer Study (Takehiko Sambe, MD, PhD) C-Path’s Predictive Safety Testing Consortium held the 3rd PSTC Japan Safety Biomarker Workshop on February 20, 2023 in Fujisawa,...